Asset Management One’s Heron Therapeutics HRTX Stock Holding History

Asset Management One’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-274,368	Closed	-$4.69M	–	1089
2016 Q3	$4.69M	Sell	274,368 -25,969	-9%	-$482K	0.07%	330
2016 Q2	$5.41M	Buy	300,337 +21,473	+8%	+$419K	0.08%	280
2016 Q1	$5.4M	Buy	278,864 +28,799	+12%	+$568K	0.08%	282
2015 Q4	$7.34M	Buy	250,065 +62,323	+33%	+$1.67M	0.11%	219
2015 Q3	$4.01M	Buy	187,742 +20,808	+12%	+$693K	0.06%	393
2015 Q2	$4.92M	Buy	+166,934	New	+$3.14M	0.07%	370

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Asset Management One's HRTX Position: Q4 2016 in Review

Asset Management One sold out of Heron Therapeutics (HRTX) in Q4 2016, closing a stake of 274,368 shares — an estimated $4.69M sold.

Asset Management One first reported a position in HRTX in Q2 2015 and held it in 6 quarters. The position peaked at $7.34M in Q4 2015. 99 funds tracked by Wall St. Rank hold HRTX as of Q4 2016.

Asset Management One reported no remaining Heron Therapeutics position as of Q4 2016 after selling out during the quarter.
Asset Management One sold 274,368 Heron Therapeutics shares in Q4 2016, an estimated $4.69M.
Asset Management One first reported a position in Heron Therapeutics in Q2 2015 and held it in 6 quarters.
Asset Management One's Heron Therapeutics position peaked at $7.34M in Q4 2015.
99 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.